Your session is about to expire
← Back to Search
Respiratory Training vs Interoceptive Exposure for Anxiety
Study Summary
This trial will compare two different treatments for anxiety - interoceptive exposure and capnometry-guided respiratory intervention - to a control group receiving psychoeducation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowExclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with Acute Stress Disorder.I have been diagnosed with an anxiety or trauma-related disorder like PTSD or panic disorder.I am not currently undergoing any treatment for anxiety.I am 18 years old or older.You are currently pregnant or breastfeeding.I can get to the lab for my study appointments.I have been diagnosed with Posttraumatic Stress Disorder.You have not experienced any episodes of psychosis in the past 6 months.I have been diagnosed with panic disorder.You have a condition called health anxiety, which involves excessive worry and fear about one's health.You have not attempted suicide in the past 6 months.I haven't used psychotropic drugs recently or have been stable on them for 3 months.I haven't used psychotropic drugs recently or have been stable on them for 3+ months.I have been diagnosed with Social Anxiety Disorder.I have been diagnosed with Generalized Anxiety Disorder.I have been diagnosed with an Adjustment Disorder with anxiety.You have not had problems with alcohol or drug addiction, except for nicotine, in the last three months.You have a fear of being in public places or situations where escape may be difficult or embarrassing.I have been diagnosed with high anxiety.I have high anxiety, scoring 8 or more on the OASIS.
- Group 1: Capnometry-Guided Respiratory Intervention (CGRI)
- Group 2: Psycho-Education (PsyEd)
- Group 3: Interoceptive Exposure (IE)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 4 Weeks
- Follow Ups: You may be asked to continue sharing information regarding the trial for 2 Months after you stop receiving the treatment.
Frequently Asked Questions
What primary goal is this clinical experiment trying to accomplish?
"This trial seeks to assess Overall Anxiety Severity and Impairment Scale over the course of Pre-Treatment (Week 0), Post-treatment (Week 5), 2-Month Follow Up (Week 13). Additionally, secondary outcomes such as Sheehan Disability Scale, Anxiety Sensitivity Composite Measure, and Modified DIAMOND will be evaluated. The former measures overall disability ranging from 0 - 30 with higher scores indicating more impairment whereas the latter captures changes in anxiety sensitivity by combining scores on ASI-3, BSQ, and TMASS into a single index."
How many participants are engaged in the current clinical trial?
"Affirmative. Clinicaltrials.gov data indicates the trial's commencement date of August 1st 2022, and its present search for 102 patients from one medical centre."
Are there any opportunities for people to register with this trial at present?
"Affirmative. Clinicaltrials.gov shows that the trial is currently enrolling patients, with 102 expected to participate across one site since it was first posted on August 1st 2022 and last updated on the same day."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Texas at Austin: < 24 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger